Alam Md Shahid, Kundu Debi
Department of Orbit, Oculoplasty, Reconstructive and Aesthetic Services, Aditya Birla Sankara Nethralaya, Kolkata (A Unit of Medical Research Foundation, Chennai), West Bengal, India.
Indian J Ophthalmol. 2022 Dec;70(12):4416-4418. doi: 10.4103/ijo.IJO_972_22.
To study the efficacy of dacryocystectomy (DCT) in reducing epiphora in cases of primary acquired nasolacrimal duct obstruction.
This was a prospective, nonrandomized, interventional study conducted over a period of 12 months. All cases who either opted or satisfied our criteria for DCT in primary acquired nasolacrimal duct obstruction (age above 70 years) were included in the study. Patients with secondary nasolacrimal duct obstruction and those undergoing revision surgeries were excluded. Patients were asked to report the percentage improvement in postoperative watering subjectively. Munk score and fluorescein dye disappearance test (FDDT) were recorded pre- and postoperatively. Wilcoxon signed ranked test was used for analysis.
Eighty-two eyes of 65 patients were included. Most of the patients (46, 70.8%) were females. The mean age was 68.46 ± 5.7 years (range: 60-85 years). The mean subjective improvement in watering was 86.8%. The P value for preoperative and postoperative difference in Munk score and FDDT score was highly significant (P = 0.00001).
Apart from providing relief from ocular discharge, DCT also provides significant improvement in watering. Patients can be preoperatively counseled regarding chances of reduction in epiphora following surgery.
研究泪囊摘除术（DCT）对减轻原发性获得性鼻泪管阻塞病例溢泪症状的疗效。
这是一项为期12个月的前瞻性、非随机、干预性研究。纳入所有选择或符合我们原发性获得性鼻泪管阻塞（年龄70岁以上）泪囊摘除术标准的病例。排除继发性鼻泪管阻塞患者和接受翻修手术的患者。要求患者主观报告术后流泪改善的百分比。术前和术后记录蒙克评分和荧光素染料消失试验（FDDT）。采用Wilcoxon符号秩和检验进行分析。
纳入65例患者的82只眼。大多数患者（46例，70.8%）为女性。平均年龄为68.46±5.7岁（范围：60 - 85岁）。流泪主观改善的平均值为86.8%。蒙克评分和FDDT评分术前与术后差异的P值具有高度显著性（P = 0.00001）。
除了缓解眼部溢液外，泪囊摘除术还能显著改善流泪症状。可在术前向患者咨询手术后排泪减少的可能性。
